1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop drugs? Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999‚ and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research‚ and (2) developing partnerships with smaller biotechnology companies. Since 1995‚ Merck had launched
Premium Expected value License Money
Analysis on Merck: Conflict and change Assessment: Merck is one of the biggest pharmaceutical companies in the world today. Although encountered with success‚ it still faces many problems today while trying to be the market leader competing against its competition. While being research and development driven company‚ Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. The main issue that seems to come
Premium Pharmaceutical industry Pharmacology
including Bayer AG and Novartis are exploring a deal for Merck & Co Inc’s consumer healthcare business‚ as they seek to gain scale in a fragmented industry‚ according to several people familiar with the matter. Reckitt Benckiser Group PLC and Procter & Gamble Co are also among the parties that have held discussions with Merck about buying the unit‚ best known for Coppertone sunscreen and Claritin allergy medicine‚ the sources said this week. The Merck business‚ which also includes Dr. Scholl’s foot
Premium Pharmacology Marketing Pharmacy
Pharmaceuticals: Merck Sustaining Long-term Advantage Through Information Technology Hiroshi Amari Working Paper No. 161 Working Paper Series Center on Japanese Economy and Business Columbia Business School December 1998 Columbia-Yale Project: Use of Software to Achieve Competitive Advantage PHARMACEUTICALS: MERCK Sustaining Long-term Advantage Through Information Technology Prepared by Hiroshi Amari Research Associate‚ Yale University William V. Rapp and Hugh T. Patrick Co-principal
Premium Clinical trial Pharmaceutical industry Drug development
c. Moody’s Investors Service downgraded the long-term senior unsecured rating of AZN from A1 to Aa2 in 2007. Assess any potential association between this downgrade and AZN’s arrangements with Merck. Paris‚ July 30‚ 2007 -- Moody’s Investors Service downgraded the long-term senior unsecured ratings of AstraZeneca plc and its guaranteed subsidiary to A1 from Aa2. This downgrade followed the announcement of AstraZeneca’s acquisition of MedImmune for a total consideration of more than US$15 billion
Premium Money
J Bus Ethics DOI 10.1007/s10551-011-1130-4 Ethical Blindness Guido Palazzo • Franciska Krings • Ulrich Hoffrage Received: 1 June 2010 / Accepted: 22 November 2011 Ó Springer Science+Business Media B.V. 2011 Abstract Many models of (un)ethical decision making assume that people decide rationally and are in principle able to evaluate their decisions from a moral point of view. However‚ people might behave unethically without being aware of it. They are ethically blind. Adopting a sensemaking
Premium Decision making Morality Decision theory
Color blindness or color vision deficiency is the inability or decreased ability to see color‚ or distinguish color differences‚ under normal lighting conditions. Color blindness affects many people in a population. "Color blind" is a term of art; there is no actual blindness but there is a fault in the development of one or more sets of retinal cones that perceive color in light and transmit that inform ation to the optic nerve. Symptoms like those of color blindness can also be produced by physical
Premium Color
INATTENTIONAL BLINDNESS Inattentional blindness‚ also known as perceptual blindness‚ is the phenomenon of not being able to see things that are actually there. This can be a result of having no internal frame of reference to perceive the unseen objects‚ or it can be the result of the mental focus or attention which cause mental distractions. The phenomenon is due to how our minds see and process information. Closely related to the subject of change blindness‚ it is an observed phenomenon of the
Premium Inattentional blindness Blindness Attention
Symbol of Blindness in King Lear Blindness is usually defined as the physical ability of the eye to see. But in King Lear by William Shakespeare‚ blindness is not just a physical quality but also a mental flaw that people possess. This mental flaw can then lead to people making bad decisions because they can’t see the truth. In King Lear‚ the recurring images of sight and blindness that are associated with the characters of Lear and Gloucester illustrate the theme of self-knowledge and consciousness
Premium William Shakespeare King Lear Blindness
Effects of Leadership in the Management Strategies of Merck and Company‚ Inc. Rana Satnani MGT-330 Management: Theory‚ Practice‚ and Application. July 2‚ 2010 Carolyn Harrison There lies a division in the business world between managers who “do things right” and leaders who “do the right things” (Bennis‚ 2007‚ p. 13). The primary difference between good managers and fantastic leaders is the ability to take risks and make independent decisions. Ethical leadership is more important today than
Premium Leadership Management Business ethics